Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA Close To Buying Elder Pharmaceuticals - Business Standard


Friday, 15 Nov 2013 06:28am EST 

Business Standard reported that Sanofi SA is close to taking over Elder Pharmaceuticals valuing the pharmaceutical company at close to INR2.200 billion. The transaction is expected to be closed in the next few weeks, a banker close to the development said. 

Company Quote

200.0
1.7 +0.86%
19 Sep 2014